Ondansetron for addiction and alcoholism? Does it work?

Does ondansetron work for alcohol use disorder?

Ondansetron, better known by its brand name, Zofran, is an anti-nausea medication that blocks one kind of serotonin receptor, known as 5-HT3. In research, a low dose of it reduced drinking in people with alcohol use disorder whose drinking began early in life, and later in a group defined by a genetic test. That is the short answer, and it comes with a large caveat.

Ondansetron is not approved by the US Food and Drug Administration, or FDA, for alcohol use disorder, or for alcoholism by any other name. Its approval covers nausea and vomiting from chemotherapy, radiation, and surgery. Any use of it for drinking is off-label and, at this point, still investigational.

I treat alcohol use disorder with naltrexone in my own practice, so I have a stake in this question, and I first wrote about this drug in 2020. At the time, a company called Adial was testing a low-dose version, called AD04, paired with a genetic test, and I expected it to be on the market within a few years. So, what happened to AD04, and is ondansetron something you should be asking your doctor about?

Serotonin has been the wrong target for drinking, at least so far.

Serotonin is one of the chemical messengers that nerve cells use to talk to one another. For decades, drug companies have made antidepressants that leave more serotonin sitting in the gap between nerve cells, the selective serotonin reuptake inhibitors, or SSRIs, and you know their names: Prozac, Zoloft, Paxil, Celexa, and Lexapro. Not one of them has ever earned approval for drinking, and they have not proven useful for it.

Ondansetron does something different with serotonin. Instead of raising the amount of it, ondansetron sits on one specific receptor, 5-HT3, and keeps serotonin from acting there. That receptor sits on the nerves that trigger vomiting, which is why the drug works so well for nausea.

Why would a receptor involved in vomiting have anything to do with drinking? One theory is that in some people the serotonin system is tuned differently from birth, with more of these receptors and a serotonin transporter that behaves differently, and that alcohol is more rewarding for them because of it. Block the receptor, the theory goes, and the pull of the next drink weakens.

That is a theory about mechanism, and I hold it loosely. What is not a theory is that the effect showed up only in people with certain gene variants, which is the whole point of AD04.

Why does a gene test decide who ondansetron helps?

One research group, first in Texas and later at the University of Virginia, spent years studying ondansetron in people with alcohol use disorder. For drinkers as a whole, the results were unimpressive. Yet, in one trial it reduced drinking in people whose alcohol problems began by age 25, and in later trials the benefit tracked with particular variants in their serotonin genes.

The genotype itself is simpler than it sounds. The variants are in the gene for the serotonin transporter, the protein that clears serotonin out of the gap between nerve cells, and in the genes for the 5-HT3 receptor that ondansetron blocks. A person is tested for a small panel of these variants, and only those who carry them are expected to benefit.

An analogy that might help is a pair of prescription eyeglasses. Your glasses were ground for your eyes, and they help you see. Hand them to your neighbor and they do nothing for her, or they give her a headache.

While this is not a perfect analogy, it is close to how AD04 is supposed to work. The drug is the same ondansetron that the FDA first approved in 1991, but the test decides whose eyes it was ground for.

So, the test comes before the drug, never after. Without the test, you are trying on a stranger’s glasses.

Where does AD04 stand in 2026?

In 2020 I wrote that a third approved medication for alcohol use disorder might be coming soon. I was wrong about the timeline. As of this writing in 2026, AD04 is not approved, and no approval date exists.

Did the drug work? Is it approved? Can you get it? Partly, no, and not for drinking, at least not on the label.

Adial’s large Phase 3 trial, the last stage of testing before a company can ask for approval, finished in 2022, and across all the patients in the study, the drug did not meet its main goal. In a group of heavy drinkers that the company had defined before the study began, it did reduce heavy drinking, and that subgroup result is what the company has carried forward. Since then the company has completed a study of how the drug moves through the body, arranged manufacturing in the United States, and announced plans for another Phase 3 trial.

That is real progress, and it is also the ordinary slow grind of drug development. A subgroup result is a reason to run another trial. It is not a reason to prescribe.

What does this mean for you today? While ondansetron is cheap and familiar, the evidence for it in drinking is thin, and if a doctor offers it to you for that purpose, you are being offered an off-label drug on the strength of an unfinished story. That is not a scandal. It is something you should be told.

What medications are approved for alcohol use disorder?

Three medications carry FDA approval for alcohol use disorder, not two, as I wrote in 2020 when I left out the oldest one. They are disulfiram, known as Antabuse, naltrexone, once sold as Revia and now a generic tablet or the monthly injection Vivitrol, and acamprosate, known as Campral. Disulfiram was approved in 1951, naltrexone for drinking in 1994, and acamprosate in 2004.

They work in three different ways. Disulfiram blocks the breakdown of alcohol so that drinking makes you flushed and sick, which makes it a deterrent rather than a treatment for craving. Acamprosate is thought to steady a nervous system that has adapted to alcohol, and it is meant for people who have already stopped drinking.

Which of the three matters most for this article? Naltrexone, the odd one out. Alcohol releases endorphins, the brain’s own reward chemicals, and naltrexone blocks the receptors those endorphins act on. Take away the reward, and over time the drinking loses its grip.

I compared the last two in an earlier post, acamprosate vs naltrexone, and naltrexone came out on top. None of the three requires a gene test. And, unlike AD04, all three are on the pharmacy shelf right now.

The Sinclair Method is the treatment I use today.

The Sinclair Method, or TSM, is naltrexone taken about one hour before drinking, every time you drink. While the drinking continues, the reward is blocked each time, and the learned habit of drinking slowly unlearns itself, a process known as pharmacological extinction. Over months, the drinks per day come down, and for many patients the desire to drink fades with them.

You do not have to stop drinking before you start. In fact, that is the point, and it is why TSM suits gray area drinkers as well as people with a diagnosis. The method takes its name from the researcher who worked it out in Finland, and I have written about how the Sinclair Method works at length.

Why prefer a method that lets drinking come down gradually? Safety. Stopping heavy daily drinking suddenly can bring on alcohol withdrawal, and severe alcohol withdrawal can include seizures. If you drink heavily every day, do not quit cold turkey on your own, and if withdrawal symptoms become severe, call 911 or go to an emergency room.

TSM lets the taper happen inside the drinking itself. With the reward blocked, most patients drink less without ever having to white-knuckle a first sober week.

Both stories began in Finland.

Interestingly, both of the ideas in this article grew up in the same small country. The extinction effect behind the Sinclair Method was worked out in Finland. Adial’s large trial of AD04 was run in Finland and other European countries, with Finnish investigators, after the earlier research in Texas and Virginia.

So, why has the United States been so slow to use what Finland worked out? Unfortunately, from Finland to the United States is a long trip. Naltrexone has been approved for drinking since 1994 and has been a cheap generic for most of that time. The American treatment industry has had three decades to notice.

Instead, the rehab model still leans on a spiritual program that is nearly a century old, with medication as an afterthought, if it is offered at all. Follow the money, and you find thirty-day programs that bill for the thirty days. A pill that lets a patient keep going to work is harder to bill for.

Still, for many people, the meetings are the part that works, and I would not talk anyone out of them. What I object to is medication being treated as a second-tier option, offered only after the program has failed. Medical treatment for drinking should be on the table on day one.

Can you drink on Zofran, or take it after drinking?

This is the question most people who land on this page are actually asking, so it deserves a plain answer. There is no documented direct interaction between ondansetron and alcohol, and the Zofran label lists no alcohol interaction. Nothing on record shows that alcohol changes how the body handles the drug, or that the drug makes you more intoxicated.

Yet, two cautions are real. Both alcohol and ondansetron can cause drowsiness, tiredness, and sometimes dizziness, and the two effects can add together, which matters if you are driving.

And if you are taking Zofran because drinking made you sick, keep in mind that the alcohol is what is making you sick. Zofran can quiet the nausea while the alcohol keeps doing its work.

The cautions that actually matter with ondansetron are on its label, and they have little to do with the drink itself. The first is QT prolongation, a change in the heart’s electrical rhythm that can become dangerous when potassium and magnesium are low, and vomiting and heavy drinking both drain those. The second is serotonin syndrome, which can occur when ondansetron is combined with serotonergic drugs such as SSRI antidepressants and the serotonin and norepinephrine reuptake inhibitors, or SNRIs.

So, Zofran is not a hangover cure, and it is not a way to keep drinking past the point where your stomach says stop. If you are reaching for an anti-nausea pill so that you can drink more, the drinking has become the problem, and it is not a bad idea to talk to your doctor about it.

Nausea from naltrexone is the reason my patients ask about Zofran.

The pharmacy websites answer the interaction question and stop there. What they leave out is why the question comes to an alcohol treatment practice at all. Nausea is the most common early side effect of naltrexone, and Sinclair Method patients hit it in the first week or two, right when they are deciding whether the method is for them. Patients have described the first few doses as a mild seasickness that came and went within hours.

What do I tell them? Fortunately, in my experience, it usually settles on its own within a couple of weeks. Taking the naltrexone with food helps, and some patients do better starting at a lower dose and working up, which is a plan to make with your doctor rather than on your own. The nausea is a nuisance, not a danger, and it is not a sign that the drug is wrong for you.

When the nausea is bad enough to make a patient want to quit, a short course of an anti-nausea medication is a reasonable thing to discuss. Ondansetron is one option, and this is where its label cautions come back. If you take an SSRI or SNRI antidepressant, the serotonin syndrome warning applies, and if you have a heart rhythm problem or your electrolytes are off from drinking, the QT warning applies.

Your doctor can weigh those against a week of queasiness. Often, the answer is a smaller dose and a little patience.

Is ondansetron addictive?

No. Ondansetron is not a controlled substance, it produces no high, and its label describes no dependence or withdrawal syndrome. While some drugs have to be tapered, patients simply stop ondansetron when the nausea stops, and there is nothing to taper.

While we are drawing distinctions, physical dependence is not addiction, and ondansetron causes neither. A drug that makes you dependent changes your body so that stopping it produces withdrawal. A drug that is addictive drives compulsive use in spite of harm.

Of course, an anti-nausea pill does neither. That is why it looked like a good candidate for treating a condition that does.

One more thing ondansetron does not do: it does not treat alcohol withdrawal. If you are shaking, sweating, and sick because you stopped drinking, an anti-nausea pill is not the treatment. A doctor is, and if the shaking is severe, or you become confused or have a seizure, an emergency room is.

Where is treatment for alcohol use disorder heading?

I believe that AD04 points in the right direction even if it never reaches a pharmacy. The idea that a gene test can tell us which patient will respond to which drug is already how parts of cancer treatment work, and there is no reason the treatment of drinking should be different. While naltrexone helps many people, it does not help everyone, and a test that could predict who is who would be worth more than any single new pill.

Yet, the other half of the future is not new at all. Medication, counseling, and, where a patient wants them, the meetings can all sit at the same table. Medicine does not have to win an argument with a support group in order to help you.

For now, the tools that exist are enough to change a life. Naltrexone is cheap, the Sinclair Method is simple, and you do not have to stop drinking to begin.

The best time to start was years ago. The next best time is today.

In Dr. Leeds’ practice, alcohol use disorder and gray area drinking are treated with naltrexone and the Sinclair Method by telemedicine throughout Florida. Patients do not have to stop drinking before the first visit, and no one is required to attend group meetings. To ask about an appointment, use the contact form.

This article is educational. It is not medical advice, and reading it does not create a doctor-patient relationship. Decisions about starting, continuing, or tapering any medication should be made with your own physician.